We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDROW icon
13501
Codere Online Luxembourg Warrants
CDROW
$4.65K ﹤0.01%
+42,308
New +$5.22K
CASH icon
13502
PUT
Pathward Financial
CASH
$1.8B
$4.64K ﹤0.01%
100
-45,500
-100% -$2.04M
DPRO
13503
PUT
Draganfly
DPRO
$180M
$4.61K ﹤0.01%
144
-16
-10% -$412
RNAC icon
13504
PUT
Cartesian Therapeutics
RNAC
$267M
$4.59K ﹤0.01%
137
-56
-29% -$2K
MXCT icon
13505
CALL
MaxCyte
MXCT
$141M
$4.59K ﹤0.01%
1,000
-1,900
-66% -$8.73K
VWE
13506
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$4.59K ﹤0.01%
5,360
+5,282
+6,772% +$6.14K
ALGS icon
13507
CALL
Aligos Therapeutics
ALGS
$43M
$4.56K ﹤0.01%
188
-316
-63% -$8.47K
RGS icon
13508
PUT
Regis Corp
RGS
$69.3M
$4.55K ﹤0.01%
205
-415
-67% -$8.93K
CELU icon
13509
CALL
Celularity
CELU
$20.1M
$4.53K ﹤0.01%
850
HARP
13510
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$4.53K ﹤0.01%
+637
New +$4.41K
CELG.RT
13511
Bristol-Myers Squibb Rights
CELG.RT
$224M
$4.51K ﹤0.01%
40,996
-1,333
-3% -$151
BITI icon
13512
ProShares Short Bitcoin Strategy ETF
BITI
$121M
$4.5K ﹤0.01%
48
-26,347
-100% -$2.75M
LOCL.WS
13513
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$4.49K ﹤0.01%
+52,770
New +$4.3K
LODE icon
13514
PUT
Comstock
LODE
$263M
$4.45K ﹤0.01%
610
-320
-34% -$1.98K
IDN icon
13515
PUT
Intellicheck
IDN
$56.9M
$4.45K ﹤0.01%
1,800
+400
+29% +$968
UCAR
13516
U Power Ltd
UCAR
$17M
$4.45K ﹤0.01%
+1
New +$6.43K
IPSC icon
13517
CALL
Century Therapeutics
IPSC
$348M
$4.42K ﹤0.01%
1,400
-4,600
-77% -$14.8K
IBOC icon
13518
CALL
International Bancshares
IBOC
$4.56B
$4.42K ﹤0.01%
100
-400
-80% -$17.4K
IMMR icon
13519
Immersion
IMMR
$249M
$4.42K ﹤0.01%
624
-127,112
-100% -$941K
CELL
13520
CALL
DELISTED
PhenomeX Inc. Common Stock
CELL
$4.41K ﹤0.01%
9,000
-12,400
-58% -$10.1K
LRMR icon
13521
PUT
Larimar Therapeutics
LRMR
$453M
$4.38K ﹤0.01%
1,400
+700
+100% +$2.86K
WCLD
13522
WisdomTree Cloud Computing Fund
WCLD
$311M
$4.38K ﹤0.01%
138
-18,409
-99% -$535K
AREN icon
13523
Arena Group
AREN
$54.8M
$4.37K ﹤0.01%
954
-22,196
-96% -$88.2K
DZSI
13524
PUT
DELISTED
DZS Inc. Common Stock
DZSI
$4.37K ﹤0.01%
1,100
-900
-45% -$5.28K
REE
13525
PUT
DELISTED
REE Automotive
REE
$4.33K ﹤0.01%
380
+110
+41% +$1.17K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.